Designing Paclitaxel Drug Delivery Systems Aimed at Improved Patient Outcomes: Current Status and Challenges
Figure 11
Survival ratio of ascitic tumor bearing mice. □ represents untreated control, ■ represents the group treated with 60 mg/kg paclitaxel emulsion, and ● represents the group treated with same quantity of paclitaxel free emulsion vehicle (reproduced with permission from Kan et al., [61]).
